How much is RxWare worth in 2026?

RxWare has a current valuation of N/A based on their Later Stage VC round and secondary market data.

How much funding has RxWare raised?

RxWare has raised $13.8M in total funding across 0 funding rounds.

RxWare

Website

RxWare valuation and funding history | Last updated: August 14, 2025

Current Valuation

N/A

As of August 14, 2025

Total Funding Raised

$13.8M

Last Round

Later Stage VC

$6.4M

Last Funding

Aug 2025

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

RxWare is currently valued at N/A as of August 14, 2025. The company has raised a total of $13.8M in funding.

Track RxWare Valuation Updates

Get notified when RxWare raises new funding or valuation changes

Explore More Data

Detailed analysis for RxWare

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock RxWare's valuation history, funding rounds, and growth metrics.

No credit card required

What is RxWare Worth in 2026?

RxWare is a leading private company in the technology sector. Track RxWare's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How RxWare Valuation is Determined

Private company valuations like RxWare's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.